524 related articles for article (PubMed ID: 24685632)
1. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
2. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
Alegret M; Cuberas-Borrós G; Vinyes-Junqué G; Espinosa A; Valero S; Hernández I; Roca I; Ruíz A; Rosende-Roca M; Mauleón A; Becker JT; Castell-Conesa J; Tárraga L; Boada M
J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
[TBL] [Abstract][Full Text] [Related]
3. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
4. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
5. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
6. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
[TBL] [Abstract][Full Text] [Related]
8. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
[TBL] [Abstract][Full Text] [Related]
10. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
11. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
[TBL] [Abstract][Full Text] [Related]
12. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
[TBL] [Abstract][Full Text] [Related]
15. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
17. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
[TBL] [Abstract][Full Text] [Related]
18. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
19. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Dukart J; Sambataro F; Bertolino A
J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
